新生學校財團法人新生醫護管理專科學校圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Anti-VEGF use in ophthalmology /

Liang, Michelle C., (1983-)

Anti-VEGF use in ophthalmology /

紀錄類型:	書目-語言資料,印刷品 : 單行本
正題名/作者:	Anti-VEGF use in ophthalmology // editors, Jay S. Duker, Michelle C. Liang.
其他題名:	Anti-vascular endothelial growth factor use in ophthalmology
其他作者:	Duker, Jay S.,
出版者:	Thorofare, NJ :SLACK Incorporated, : c2017.,
面頁冊數:	xiii, 222 p. :ill. (some col.) ; : 23 cm.;
標題:	Therapeutics, Ophthalmological. -
ISBN:	9781630913212 (pbk.) :

Anti-VEGF use in ophthalmology /
Anti-VEGF use in ophthalmology /Anti-vascular endothelial growth factor use in ophthalmologyeditors, Jay S. Duker, Michelle C. Liang. - Thorofare, NJ :SLACK Incorporated,c2017. - xiii, 222 p. :ill. (some col.) ;23 cm.

Includes bibliographical references and index.

Vascular endothelial growth factor : background and history / Anthony Joseph and Ehsan Rahimy -- Development of anti-vascular endothelial growth factor agents / Maya H. Maloney and Sophie J. Bakri -- Available anti-vascular endothelial growth factor agents / Angeline Mariani-Derham and David M. Brown -- Agents under study / Anthony Joseph, Elham Rahimy, and Ehsan Rahimy -- Intravitreal delivery / Nora Muakkassa, Kendra Klein, and Elias Reichel -- Sustained anti-vascular endothelial growth factor delivery options / Michael N. Cohen, Chirag P. Shah, and Jeffrey S. Heier -- Neovascular age-related macular degeneration / Michael D. Lewen and Andre J. Witkin -- Choroidal neovascularization, not age-related macular degeneration / Darin R. Goldman -- Diabetic macular edema / Emily D. Cole, Eduardo A. Novais, and Nadia K. Waheed -- Proliferative diabetic retinopathy / Sabin Dang and Chirag P. Shah -- Retinal vein occlusion / Shilpa Desai and Caroline R. Baumal -- Uveitis / Lana M. Rifkin -- Retinopathy of prematurity / Nikisha A. Kothari and Audina M. Berrocal -- Miscellaneous retinal and choroidal diseases / Michael D. Tibbetts -- Neovascular glaucoma / Manik Goel and Joel S. Schuman -- Glaucoma surgery / Jessica J. Moon and Cynthia Mattox -- Anterior segment diseases / Alessandro Abbouda, Bijan Khaksari, and Pedram Hamrah.

"The introduction of anti-vascular endothelial growth factor (VEGF) agents has revolutionized therapy for a host of ocular diseases associated with leakage from normal blood vessels and pathologic blood vessel growth. Anti-VEGF Use in Ophthalmology is an all-inclusive reference designed to provide detailed, up-to-date, and clinically relevant information on the current use of anti-VEGF agents in the treatment of all ocular conditions. Drs. Jay S. Duker and Michelle C. Liang have assembled a prestigious group of contributors who pool their collective expertise in this comprehensive book. Anti-VEGF Use in Ophthalmology is split into two sections with the first providing the history of VEGF and an overview of anti-VEGF agents and different routes of drug delivery, as it is important for eye care providers to be familiar with up-to-date aspects of the medications and indications for use. The second section details the clinical uses of anti-VEGF agents in numerous ocular diseases, from the anterior segment including cornea and glaucoma to uveitis and various retinal and choroidal diseases. Each chapter in this section summarizes the disease process and utilizes high-quality ocular imaging to demonstrate the therapeutic use of the anti-VEGF agents. Anti-VEGF Use in Ophthalmology combines the theory and applications of anti-VEGF agents, making it not only a great learning tool for beginners but also a useful reference tool for a wide range of eye care professionals including optometrists, residents, comprehensive ophthalmologists, as well as specialists in anterior segment, pediatrics, and vitreoretinal disease"--Provided by publisher.

ISBN: 9781630913212 (pbk.) :NT3102

LCCN: 2017010954Subjects--Topical Terms:

193103
Therapeutics, Ophthalmological.

LC Class. No.: RE991 / .A58 2017

Dewey Class. No.: 617.7/061

National Library of Medicine Call No.: 2017 F-163

Anti-VEGF use in ophthalmology /
LDR:03834nam a2200277 a 4500 001 205039
005 20191112101831.0
008 191118s2017 njua b 001 0 eng
010 $a 2017010954
020 $a 9781630913212 (pbk.) : $c NT3102
020 $a 9781630913229 (Epub)
020 $a 9781630913236 (Web)
035 $a 00011843
040 $a DNLM $b eng $e rda $c DNLM
041 0 $a eng
042 $a pcc
050 4 $a RE991 $b .A58 2017
060 0 0 $a 2017 F-163
060 1 0 $a WW 166
082 0 4 $a 617.7/061 $2 23
245 0 0 $a Anti-VEGF use in ophthalmology / $c editors, Jay S. Duker, Michelle C. Liang.
246 1 $a Anti-vascular endothelial growth factor use in ophthalmology
260 $a Thorofare, NJ : $c c2017. $b SLACK Incorporated,
300 $a xiii, 222 p. : $b ill. (some col.) ; $c 23 cm.
504 $a Includes bibliographical references and index.
505 0 $a Vascular endothelial growth factor : background and history / Anthony Joseph and Ehsan Rahimy -- Development of anti-vascular endothelial growth factor agents / Maya H. Maloney and Sophie J. Bakri -- Available anti-vascular endothelial growth factor agents / Angeline Mariani-Derham and David M. Brown -- Agents under study / Anthony Joseph, Elham Rahimy, and Ehsan Rahimy -- Intravitreal delivery / Nora Muakkassa, Kendra Klein, and Elias Reichel -- Sustained anti-vascular endothelial growth factor delivery options / Michael N. Cohen, Chirag P. Shah, and Jeffrey S. Heier -- Neovascular age-related macular degeneration / Michael D. Lewen and Andre J. Witkin -- Choroidal neovascularization, not age-related macular degeneration / Darin R. Goldman -- Diabetic macular edema / Emily D. Cole, Eduardo A. Novais, and Nadia K. Waheed -- Proliferative diabetic retinopathy / Sabin Dang and Chirag P. Shah -- Retinal vein occlusion / Shilpa Desai and Caroline R. Baumal -- Uveitis / Lana M. Rifkin -- Retinopathy of prematurity / Nikisha A. Kothari and Audina M. Berrocal -- Miscellaneous retinal and choroidal diseases / Michael D. Tibbetts -- Neovascular glaucoma / Manik Goel and Joel S. Schuman -- Glaucoma surgery / Jessica J. Moon and Cynthia Mattox -- Anterior segment diseases / Alessandro Abbouda, Bijan Khaksari, and Pedram Hamrah.
520 $a "The introduction of anti-vascular endothelial growth factor (VEGF) agents has revolutionized therapy for a host of ocular diseases associated with leakage from normal blood vessels and pathologic blood vessel growth. Anti-VEGF Use in Ophthalmology is an all-inclusive reference designed to provide detailed, up-to-date, and clinically relevant information on the current use of anti-VEGF agents in the treatment of all ocular conditions. Drs. Jay S. Duker and Michelle C. Liang have assembled a prestigious group of contributors who pool their collective expertise in this comprehensive book. Anti-VEGF Use in Ophthalmology is split into two sections with the first providing the history of VEGF and an overview of anti-VEGF agents and different routes of drug delivery, as it is important for eye care providers to be familiar with up-to-date aspects of the medications and indications for use. The second section details the clinical uses of anti-VEGF agents in numerous ocular diseases, from the anterior segment including cornea and glaucoma to uveitis and various retinal and choroidal diseases. Each chapter in this section summarizes the disease process and utilizes high-quality ocular imaging to demonstrate the therapeutic use of the anti-VEGF agents. Anti-VEGF Use in Ophthalmology combines the theory and applications of anti-VEGF agents, making it not only a great learning tool for beginners but also a useful reference tool for a wide range of eye care professionals including optometrists, residents, comprehensive ophthalmologists, as well as specialists in anterior segment, pediatrics, and vitreoretinal disease"--Provided by publisher.
650 0 $a Therapeutics, Ophthalmological. $3 193103
650 0 $a Vascular endothelial growth factors $x Antagonists. $3 397057
650 0 $a Vascular endothelial growth factors $x Therapeutic use. $3 397058
650 1 2 $a Eye Diseases $x drug therapy. $3 268521
650 2 2 $a Vascular Endothelial Growth Factor A $x antagonists & inhibitors. $3 397059
650 2 2 $a Angiogenesis Inhibitors $x therapeutic use. $3 397060
650 2 2 $a Neovascularization, Pathologic $x drug therapy. $3 397061
700 1 $a Duker, Jay S., $d 1958- $3 321829
700 1 $a Liang, Michelle C., $d 1983- $3 397056